We have observed
16 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Estimation of drug-metabolizing capacity
Bone substitute material with biologically active coating
Angiostatin chimeras and uses thereof
Increasing the viability of viable biological material
ANTIBACTERIAL MICROELEMENT CHELATES AND THE USE THEREOF IN ANIMAL FEEDS
Feed additive of plant origin
TISSUE SUBSTITUTE MATERIAL WITH BIOLOGICALLY ACTIVE COATING
MODIFIED MATRIX PROTEINS OF VESICULAR STOMATITIS VIRUS
Immunogenic nanomedicine composition and preparation and uses thereof
Treatment and prevention of cardiac arrhythmias
PREIMPLANTATION ASSESSMENT OF EMBRYOS THROUGH DETECTION OF FREE EMBRYONIC DNA
SOIL BACTERIA FOR INOCULATING STRESS SOILS
VIABILITY ASSESSMENT OF IN VITRO CULTURED HUMAN EMBRYOS FROM THE CULTURE MEDIUM
DESETHYLAMIODARONE FOR USE IN CANCER TREATMENT
COMBINATION OF LOW DOSE IMMUNE CHECKPOINT BLOCKADE WITH HIGH DOSE IL-2 FOR TREATING METASTATIC CANCER
STAPLED PEPTIDES AND USES THEREOF